Journal for ImmunoTherapy of Cancer (Nov 2020)
499 AT1636, a colon cancer survivor-derived antibody recognizes a previously unidentified truncated, O-mannosylated 70kDa variant of E-cadherin
- Evelien Dekker,
- Tim Beaumont,
- Sabrina Merat,
- Mark Kwakkenbos,
- Lina Bartels,
- Dorien van der Berg,
- Koen Wagner,
- Arjen Bakker,
- Kelly Maijoor,
- Martino Bohne,
- Camille Bru,
- Veronika Kattler,
- Yvonne Claassen,
- Victorine Roos,
- Frank Kallenberg,
- Jan Medema,
- Paul Hensbergen
Affiliations
- Evelien Dekker
- 1 Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- Tim Beaumont
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Sabrina Merat
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Mark Kwakkenbos
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Lina Bartels
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Dorien van der Berg
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Koen Wagner
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Arjen Bakker
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Kelly Maijoor
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Martino Bohne
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Camille Bru
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Veronika Kattler
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Yvonne Claassen
- 1AIMM Therapeutics, Amsterdam, Netherlands
- Victorine Roos
- 2Cancer Centre Amsterdam, Amsterdam, Netherlands
- Frank Kallenberg
- 2Cancer Centre Amsterdam, Amsterdam, Netherlands
- Jan Medema
- 2Cancer Centre Amsterdam, Amsterdam, Netherlands
- Paul Hensbergen
- 3Leiden University Medical Center, Leiden, Netherlands
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0499
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.
